Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vera Therapeutics Inc Cl A (VERA)

Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vera Therapeutics Inc Cl A 2000 SIERRA POINT PARKWAY SUITE 1200 BRISBANE CA 94005 USA

www.veratx.com Employees: 249 P: 650-770-0077

Sector:

Medical

Description:

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,772,895
Enterprise Value, $K 2,493,005
Shares Outstanding, K 71,356
Float, K 59,725
% Float 83.70%
Short Interest, K 8,251
Short Float 11.56%
Days to Cover 6.19
Short Volume Ratio 0.59
% of Insider Shareholders 16.30%
% of Institutional Shareholders 99.21%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -299,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -91,100 K
EBIT, $ -315,470 K
EBITDA, $ -320,130 K

Growth:

1-Year Return 42.96%
3-Year Return 400.77%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.39 on 02/26/26
Next Earnings Date 05/05/26
Earnings Per Share ttm -4.66
EPS Growth vs. Prev Qtr -10.32%
EPS Growth vs. Prev Year -93.06%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 01/29/96
Dividend Payout Ratio 0.00%

VERA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.72%
Return-on-Assets % -49.10%
Profit Margin % 0.00%
Debt/Equity 0.12
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.75
Book Value/Share 8.48
Interest Coverage -38.79
60-Month Beta 1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.